Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Telcagepant> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Telcagepant abstract "Telcagepant (formerly MK-0974) was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal potency to rizatriptan and zolmitriptan in two Phase III clinical trials. The company has now terminated development of the drug.".
- Telcagepant atcPrefix "none".
- Telcagepant casNumber "781649-09-0".
- Telcagepant fdaUniiCode "D42O649ALL".
- Telcagepant iupacName "N-[(3R,6S)-6-(2,3-Difluorophenyl)hexahydro-2-oxo-1-(2,2,2-trifluoroethyl)-1H-azepin-3-yl]-4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxamide".
- Telcagepant pubchem "11319053".
- Telcagepant thumbnail Telcagepant_structure.svg?width=300.
- Telcagepant wikiPageID "21594484".
- Telcagepant wikiPageRevisionID "605102221".
- Telcagepant atcPrefix "none".
- Telcagepant c "26".
- Telcagepant casNumber "781649".
- Telcagepant chembl "236593".
- Telcagepant chemspiderid "9494017".
- Telcagepant eliminationHalfLife "-28800.0".
- Telcagepant f "5".
- Telcagepant h "27".
- Telcagepant hasPhotoCollection Telcagepant.
- Telcagepant inchi "1".
- Telcagepant inchikey "CGDZXLJGHVKVIE-DNVCBOLYBL".
- Telcagepant iupacName "N-[-6-hexahydro-2-oxo-1--1H-azepin-3-yl]-4--1-piperidinecarboxamide".
- Telcagepant iupharLigand "703".
- Telcagepant kegg "D09391".
- Telcagepant legalStatus "Experimental".
- Telcagepant molecularWeight "566.5283".
- Telcagepant n "6".
- Telcagepant o "3".
- Telcagepant pubchem "11319053".
- Telcagepant routesOfAdministration "Oral".
- Telcagepant smiles "Fc1ccccc1CCCC3NCN5CCCn2c4cccnc4nc2=O".
- Telcagepant smiles "O=CN5CCCCC5".
- Telcagepant stdinchi "1".
- Telcagepant stdinchikey "CGDZXLJGHVKVIE-DNVCBOLYSA-N".
- Telcagepant unii "D42O649ALL".
- Telcagepant verifiedfields "changed".
- Telcagepant verifiedrevid "477861300".
- Telcagepant subject Category:Antimigraine_drugs.
- Telcagepant subject Category:Azepanes.
- Telcagepant subject Category:Imidazopyridines.
- Telcagepant subject Category:Lactams.
- Telcagepant subject Category:Organofluorides.
- Telcagepant subject Category:Piperidines.
- Telcagepant subject Category:Ureas.
- Telcagepant type Abstraction100002137.
- Telcagepant type Chemical114806838.
- Telcagepant type Compound114818238.
- Telcagepant type Material114580897.
- Telcagepant type Matter100020827.
- Telcagepant type OrganicCompound114727670.
- Telcagepant type Part113809207.
- Telcagepant type PhysicalEntity100001930.
- Telcagepant type Relation100031921.
- Telcagepant type Substance100019613.
- Telcagepant type Urea115085472.
- Telcagepant type Ureas.
- Telcagepant type Drug.
- Telcagepant type DrugProduct.
- Telcagepant type FunctionalSubstance.
- Telcagepant comment "Telcagepant (formerly MK-0974) was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal potency to rizatriptan and zolmitriptan in two Phase III clinical trials. The company has now terminated development of the drug.".
- Telcagepant label "Telcagepant".
- Telcagepant label "Telcagepant".
- Telcagepant sameAs Telcagepant.
- Telcagepant sameAs m.05msb7x.
- Telcagepant sameAs Q5675567.
- Telcagepant sameAs Q5675567.
- Telcagepant sameAs Telcagepant.
- Telcagepant wasDerivedFrom Telcagepant?oldid=605102221.
- Telcagepant depiction Telcagepant_structure.svg.
- Telcagepant isPrimaryTopicOf Telcagepant.